Ask AI
ProCE Banner Series

Targeting TROP-2 and TIGIT: Experts Discuss How ADCs and Immunotherapeutic Combinations Are Transforming Lung Cancer Treatment

Gain a deeper understanding of the mechanisms of action and rationale for targeting TIGIT and TROP-2 in lung cancer based on recent clinical data and novel targeted therapies to increase clinical trial enrollment and enhance patient outcomes through a certified on-demand webcast, expert-authored ClinicalThought commentary, and accompanying downloadable slides.

  AMA
Who Should Attend

This educational activity is intended for medical oncologists and other healthcare professionals who care for patients with lung cancer. 

All Events

Targeting TROP-2 and TIGIT: Experts Discuss How ADCs and Immunotherapeutic Combinations Are Transforming Lung Cancer Treatment

Upcoming Events

August

28

2025

11:30 AM - 12:30 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners' knowledge, confidence, and competence at integrating novel therapies targeting TROP-2 or TIGIT into the care of patients with lung cancer.

Target Audience
This educational activity is intended for medical oncologists and other healthcare professionals who care for patients with lung cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Educate patients and colleagues on the mechanisms of action and clinical rationale for targeting TROP-2 and TIGIT in lung cancer
  • Appraise emerging clinical data evaluating the use of novel therapies targeting TROP-2 and TIGIT in lung cancer
  • Assess the eligibility of patients with lung cancer for enrollment on clinical trials of novel therapies targeting TROP-2 and TIGIT with the potential to enhance clinical outcomes
  • Evaluate strategies to address disparities in access to novel therapies and clinical trials in rural, Black, and underserved patients with lung cancer

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191